跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 999 条关于
“dedifferentiated/pleomorphic liposarcoma”
全部
999
临床试验
936
药物
3
机构
0
资讯
60
去年
Pembrolizumab Plus Radiation and Surgery Improves Outcomes in Stage III Soft-Tissue Sarcoma
去年
Pembrolizumab Improves Disease-Free Survival in Soft Tissue Sarcoma Patients
去年
Trabectedin and Nivolumab Combination Shows Promise in Long-Term Control of Dedifferentiated Liposarcoma
去年
Brigimadlin Shows Promise in Treating Dedifferentiated Liposarcoma
3个月前
Abemaciclib Demonstrates Significant Efficacy in Phase 3 Trial for Rare Dedifferentiated Liposarcoma
去年
Pembrolizumab Plus Radiotherapy and Surgery Improves DFS in Stage III Soft Tissue Sarcoma
去年
Siremadlin Plus Ribociclib Shows Promise in MDM2/CDK4-Amplified Liposarcoma
去年
Intensity Therapeutics' Sarcoma Trial INT230-6 Authorized to Continue by DMC
去年
Immunotherapy Advances in Sarcoma Treatment: Targeting the Tumor Microenvironment and Cancer Testis Antigens
去年
Novel Sarcoma Therapies Show Promise in Early-Phase Studies at ESMO 2024
第 1 页，共 6 页
上一页
下一页
